fda warning letters compounded semaglutide october 2025 Drug Recalls and Warnings: Recalls for and Tirzepatide, Wegovy; Facility Congress Introduces SAFE Drugs Act
Description
Stevens for the execution of in vitro activity assays
Results from Eli Lilly's Phase 2 trial (Jastreboff et al., New England Journal of Medicine, 2023) reported mean body weight reductions of approximately 1724% over 48 weeks depending on dose, which has generated considerable scientific interest
The drawbacks of insulin treatment include invasive administration along with risks of hypoglycemia (2) and weight gain (3)
GLP-1 medications are prescription-only, and they're not for everyone
Why Dose Increases Matter for GLP-1s When it comes to GLP-1 dose titration, semaglutide and tirzepatide are gradually ramped up for two distinct reasons: To give your body time to adapt to any side effects
This principle applies to all the advanced compounds we offer, from metabolic peptides like Tirzepatide to regenerative compounds like BPC-157
